HighMark Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-14
Closed -$3K 533
2022
Q1
$3K Hold
14
﹤0.01% 420
2021
Q4
$4K Hold
14
﹤0.01% 385
2021
Q3
$4K Buy
+14
New +$3.59K ﹤0.01% 393

Other funds holding RGEN

HighMark Wealth Management's RGEN Position: Q2 2022 in Review

HighMark Wealth Management sold out of Repligen (RGEN) in Q2 2022, closing a stake of 14 shares — an estimated $3K sold.

HighMark Wealth Management first reported a position in RGEN in Q3 2021 and held it in 3 quarters. The position peaked at $4K in Q4 2021. 404 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.

  • HighMark Wealth Management reported no remaining Repligen position as of Q2 2022 after selling out during the quarter.
  • HighMark Wealth Management sold 14 Repligen shares in Q2 2022, an estimated $3K.
  • HighMark Wealth Management first reported a position in Repligen in Q3 2021 and held it in 3 quarters.
  • HighMark Wealth Management's Repligen position peaked at $4K in Q4 2021.
  • 404 funds tracked by Wall St. Rank held Repligen as of Q2 2022.

Based on HighMark Wealth Management's 13F filing for Q2 2022, filed 19 Jul 2022.